AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
LMNR

Limoneira Co Common Stock (LMNR) fair value

Consumer Defensive · Farm Products · NASDAQ · United States
$10.77-1.73%
Market cap $195MNext earnings 2026-09-09Updated Oct 24, 2026
Our verdict
Trades 48% below our fair value
Price
$10.77
Model fair valueConfidence: low
about $20.83
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Analyst consensus.
ACCE opinionLimoneira Co Common Stock (LMNR)
Fair value
Not available
ACCE price target
$12.10
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $10.77 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
33
out of 100
Analysts
67% buy
3 covering
1-year return
-26.3%
Dividend yield
0.00%

Limoneira Co Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Limoneira grows and sells lemons, avocados and other specialty citrus from its own orchards in California, with a legacy real estate and water-rights business alongside the farming. The moat is land and water: a large, established acreage base and water access that a new entrant cannot easily replicate in California's agriculture market. The near-term picture is weak, though. Revenue fell 7.7% in the latest reported period, the gross margin is negative at -8.1%, and return on equity sits at -24.8%, so the operating case rests on the 3.4% operating margin and the company's ability to turn orchard assets into cash. At 13.6x forward earnings the stock is priced for a recovery that the trailing numbers do not yet show, and a score of 36/100 with no index membership suggests the market has not been rewarding that bet. The thesis needs a clear view on whether volumes and pricing stabilise before it merits deeper work.

AI-assisted·How I use AIWritten Oct 18, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where LMNR's valuation models land
Price
$10.77
Model fair valueConfidence: low
about $20.83
Model
Fair value
Upside
Analyst consensus
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish67% buy · 3 covering analysts
● Strong buy 2● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-9.8%
1 month
-10.9%
3 months
-17.5%
6 months
-15.5%
YTD
-14.7%
1 year
-26.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
15 Oct 2026, 00:00 CESTACCE price target$12.10first publication$12.06

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full LMNR page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth43Value38Quality32Momentum17Total33
Valuation
Trailing P/E
no data
Forward P/E
23.9x
PEG
no data
P/B
1.66x
EV / Revenue
2.6x
Book value/sh
$7.29
Enterprise value
$332M
Profitability
ROE
-24.8%
FCF yield
-10.01%
ROIC
-5.3%
Health and risk
Debt / equity
0.43
Dividend yield
0.00%
Beta
0.33

Price

-28.4% · 1Y

Ask anything about LMNR

Answered from Limoneira Co Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 17% of peers
low -202%-25%high 12%
Div yieldbetter than 67% of peers
low 0.0%0.0%high 1.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
LMNR Limoneira Co Common Stock$10.77----24.8%3233
ALCO Alico Inc. Common Stock$37.17$1995% above176.6x0.7%4545
AFRI Forafric Global PLC Ordinary Shares$11.82----202.2%1331
VFF Village Farms International Inc. Common Shares$2.58$433% below15.1x7.5%7157
CAMANCHACA.SN Pes CamanchacaCLP 89.00--7.6x12.1%6174
LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)$3.60$1170% above--4.3%2723
VITL Vital Farms Inc. Common Stock$9.14---0.1%4231

Sector report card

Where LMNR ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Sep 9, 2026
    Limoneira Company Announces Third Quarter Fiscal Year 2026 Financial Results
  • Business Wire•Aug 26, 2026
    Limoneira to Announce Third Quarter 2026 Financial Results on September 9, 2026
  • Business Wire•Aug 17, 2026
    Limoneira Enters Agreement to Sell Windfall Farms Vineyard Property for $15 Million All Cash via Public Auction
2 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 22
8-KCurrent reportPeriod 2026-10-21
View on SEC →
Oct 2
Form 4Insider transactionPeriod 2026-10-01
View on SEC →
September 2026
Sep 9
10-QQuarterly reportPeriod 2026-07-31
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR